SPERM Stock Overview
Spermosens AB engages in the research, development, and commercialization of diagnostic technology in health and medical care in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Spermosens AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.14 |
| 52 Week High | kr0.97 |
| 52 Week Low | kr0.11 |
| Beta | 0.19 |
| 1 Month Change | -42.39% |
| 3 Month Change | -76.63% |
| 1 Year Change | -84.44% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -98.06% |
Recent News & Updates
Recent updates
Shareholder Returns
| SPERM | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | -21.6% | -0.8% | -1.6% |
| 1Y | -84.4% | -5.1% | 7.8% |
Return vs Industry: SPERM underperformed the Swedish Biotechs industry which returned -5.1% over the past year.
Return vs Market: SPERM underperformed the Swedish Market which returned 7.8% over the past year.
Price Volatility
| SPERM volatility | |
|---|---|
| SPERM Average Weekly Movement | 33.4% |
| Biotechs Industry Average Movement | 9.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 12.8% |
| 10% least volatile stocks in SE Market | 3.4% |
Stable Share Price: SPERM's share price has been volatile over the past 3 months.
Volatility Over Time: SPERM's weekly volatility has increased from 20% to 33% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 7 | Ulrik Nilsson | www.spermosens.com |
Spermosens AB engages in the research, development, and commercialization of diagnostic technology in health and medical care in Sweden. The company provides male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding.
Spermosens AB Fundamentals Summary
| SPERM fundamental statistics | |
|---|---|
| Market cap | kr5.77m |
| Earnings (TTM) | -kr12.20m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.5x
P/E RatioIs SPERM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SPERM income statement (TTM) | |
|---|---|
| Revenue | kr0 |
| Cost of Revenue | kr0 |
| Gross Profit | kr0 |
| Other Expenses | kr12.20m |
| Earnings | -kr12.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 75.0% |
How did SPERM perform over the long term?
See historical performance and comparison